Study to Collect Safety and ECG Data on Brolucizumab 6 mg Intravitreal Treatment in Patients With Wet AMD
Clinical trial NCT03954626 · COMPLETED
Trial details
- NCT number
- NCT03954626
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-07
- Primary completion
- 2019-07-09
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.